Keeping an eye on circadian time in clinical research and medicine
- PMID: 36567263
- PMCID: PMC9790849
- DOI: 10.1002/ctm2.1131
Keeping an eye on circadian time in clinical research and medicine
Abstract
Background: Daily rhythms are observed in humans and almost all other organisms. Most of these observed rhythms reflect both underlying endogenous circadian rhythms and evoked responses from behaviours such as sleep/wake, eating/fasting, rest/activity, posture changes and exercise. For many research and clinical purposes, it is important to understand the contribution of the endogenous circadian component to these observed rhythms.
Content: The goal of this manuscript is to provide guidance on best practices in measuring metrics of endogenous circadian rhythms in humans and promote the inclusion of circadian rhythms assessments in studies of health and disease. Circadian rhythms affect all aspects of physiology. By specifying minimal experimental conditions for studies, we aim to improve the quality, reliability and interpretability of research into circadian and daily (i.e., time-of-day) rhythms and facilitate the interpretation of clinical and translational findings within the context of human circadian rhythms. We describe protocols, variables and analyses commonly used for studying human daily rhythms, including how to assess the relative contributions of the endogenous circadian system and other daily patterns in behaviours or the environment. We conclude with recommendations for protocols, variables, analyses, definitions and examples of circadian terminology.
Conclusion: Although circadian rhythms and daily effects on health outcomes can be challenging to distinguish in practice, this distinction may be important in many clinical settings. Identifying and targeting the appropriate underlying (patho)physiology is a medical goal. This review provides methods for identifying circadian effects to aid in the interpretation of published work and the inclusion of circadian factors in clinical research and practice.
Keywords: chronobiology; chronomedicine; circadian; circadian medicine; daily; diurnal; human; time-of-day; translational.
© 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.
Conflict of interest statement
Klerman ‐ Consulting: American Academy of Sleep Medicine foundation, Circadian Therapeutics, National Sleep Foundation, Sleep Research Society Foundation. Yale University Press. Partner owns Chronsulting. Brager ‐ Consulting: National Academy of Sports Medicine, O2X Max Human Performance, Voices in Sport, WHOOP, Inc., Momentous, Inc., Molecule, Inc., LifeAid Beverage Company, Inc. Carskadon ‐ Editor in Chief, Sleep Research Society gold open access journal SLEEP Advances. Depner ‐ Travel support from Sleep Research Society, Consulting: Elsevier Inc. Foster ‐ Circadian Therapeutics, National Sleep Foundation. Goel ‐ NG serves on the Board of Directors of the Sleep Research Society, as President‐Elect (June 2021–June 2022) and as President (June 2022–Present). She receives a stipend for these officer roles. NG also serves on the Board of Directors of the Sleep Research Society Foundtion and on the Board of Directors of the Associated Professional Sleep Societies. NG received an honorarium for a research presentation at Northwestern University Grand Rounds. Harrington ‐ None. Holloway ‐ None. Lipton ‐ None. Knauert ‐ Member of Serca LLC, American College of Chest Physicians. LeBourgeois ‐ None. Merrow ‐ None. Montagnese ‐ None. Ning‐ None. Ray ‐ None. Scheer ‐ served on the Board of Directors for the Sleep Research Society and has received consulting fees from the University of Alabama at Birmingham; his interests were reviewed and managed by Brigham and Women's Hospital and Partners HealthCare in accordance with their conflict of interest policies and his consultancies are not related to the current work. Shea ‐ None. Skene ‐ None. Spies ‐ Personal fees from Georg Thieme Verlag. Dr. Spies has patent 10 2014 215 211.9 licensed, 10 2018 114 364.8 licensed, 10 2018 110 275.5 licensed, 50 2015 010 534.8 licensed, 50 2015 010 347.7 licensed and 10 2014 215 212.7 licensed. Staels ‐ None. St‐Onge‐ None. Tiedt ‐ None. Zee ‐ Consulting: Eisai, Jazz, Atria Health, CVS Caremark, Idorsia, stock ownership: Teva. Burgess ‐ Consulting: Natrol, LLC, Moving Mindz, Pty Ltd, F. Hoffmann‐La Roche Ltd.
Figures
References
-
- Lo EH, Albers GW, Dichgans M, et al. Circadian biology and stroke. Stroke. 2021;52:2180–2190. - PubMed
Publication types
MeSH terms
Grants and funding
- 107849/Z/15/Z/WT_/Wellcome Trust/United Kingdom
- U54 AG062322/AG/NIA NIH HHS/United States
- R01 NS093415/NS/NINDS NIH HHS/United States
- R01 NS114526/NS/NINDS NIH HHS/United States
- K01 HL145099/HL/NHLBI NIH HHS/United States
- R01 HL151368/HL/NHLBI NIH HHS/United States
- I01 HX002534/HX/HSRD VA/United States
- R01 NS099055/NS/NINDS NIH HHS/United States
- R01 HL141706/HL/NHLBI NIH HHS/United States
- R01 HL140574/HL/NHLBI NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- 223704/Z/21/Z/WT_/Wellcome Trust/United Kingdom
- R01 HL142648/HL/NHLBI NIH HHS/United States
- R61 MH117157/MH/NIMH NIH HHS/United States
- R01 DK117488/DK/NIDDK NIH HHS/United States
- P30 DK048520/DK/NIDDK NIH HHS/United States
- R01 DK102624/DK/NIDDK NIH HHS/United States
- R01 DK128154/DK/NIDDK NIH HHS/United States
- R01 DK124280/DK/NIDDK NIH HHS/United States
- U01 HL146245/HL/NHLBI NIH HHS/United States
- R01 MH121531/MH/NIMH NIH HHS/United States
- R35 HL155681/HL/NHLBI NIH HHS/United States
- P50 HD105351/HD/NICHD NIH HHS/United States
- UL1 TR001863/TR/NCATS NIH HHS/United States
- R01 HD087707/HD/NICHD NIH HHS/United States
- R01 NS067139/NS/NINDS NIH HHS/United States
- R01 HD103665/HD/NICHD NIH HHS/United States
- R01 DK127254/DK/NIDDK NIH HHS/United States
- K23 HL138229/HL/NHLBI NIH HHS/United States
- RF1 AG059867/AG/NIA NIH HHS/United States
- R15 GM126545/GM/NIGMS NIH HHS/United States
- R01 HL153969/HL/NHLBI NIH HHS/United States
- R01 HD107064/HD/NICHD NIH HHS/United States
- U01 NS114001/NS/NINDS NIH HHS/United States
- R01 HL142116/HL/NHLBI NIH HHS/United States
- R01 AG053838/AG/NIA NIH HHS/United States
- R01 HL140580/HL/NHLBI NIH HHS/United States
- R03 HL157009/HL/NHLBI NIH HHS/United States
- R21 NS113065/NS/NINDS NIH HHS/United States
- R01 AA025593/AA/NIAAA NIH HHS/United States
- RF1 NS126547/NS/NINDS NIH HHS/United States
- R21 DA052861/DA/NIDA NIH HHS/United States
- RF1 NS067139/NS/NINDS NIH HHS/United States
- P20 GM139743/GM/NIGMS NIH HHS/United States
- UE5 NS128293/NS/NINDS NIH HHS/United States
- WT106174/Z/14/ZMA/WT_/Wellcome Trust/United Kingdom
- R01 NR018891/NR/NINR NIH HHS/United States
- P01 AG011412/AG/NIA NIH HHS/United States
- R01 HL142058/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources